Edition:
United States

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

33.40USD
17 Nov 2017
Change (% chg)

$-0.33 (-0.98%)
Prev Close
$33.73
Open
$33.44
Day's High
$33.81
Day's Low
$33.30
Volume
115,149
Avg. Vol
134,610
52-wk High
$46.81
52-wk Low
$28.49

Chart for

About

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It... (more)

Overall

Beta: 1.12
Market Cap(Mil.): $1,455.08
Shares Outstanding(Mil.): 43.57
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.35 15.79
EPS (TTM): -- -- --
ROI: -- 15.11 12.01
ROE: -- 16.52 15.91

BRIEF-Repligen reports Q3 adjusted non-GAAP earnings per share $0.15

* Q3 earnings per share view $0.11 -- Thomson Reuters I/B/E/S

Nov 09 2017

BRIEF-Repligen extends long term supply agreement with Purolite for Protein A ligands

* Repligen extends long term supply agreement with Purolite for Protein A ligands

Nov 07 2017

BRIEF-Roy Eddleman reports 11 pct passive stake in Repligen‍​

* Roy T. Eddleman reports 11.0 percent passive stake in Repligen Corp as of August 1, 2017 - sec filing‍​ Source text: (http://bit.ly/2vRsiEb) Further company coverage:

Aug 21 2017

BRIEF-Repligen prices public offering of shares of common stock

* Repligen Corporation prices public offering of shares of common stock

Jun 27 2017

BRIEF-REPLIGEN CORP ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK

* REPLIGEN CORPORATION ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK

Jun 26 2017

BRIEF-Repligen and Spectrum to join forces

* Repligen Corp - deal expected to be accretive to repligen earnings per share in fiscal 2018

Jun 23 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $138.00 -0.87
Novartis AG (NOVN.S) CHF83.30 +0.90
Roche Holding Ltd. (ROG.S) CHF230.10 +1.10
Roche Holding Ltd. (RO.S) CHF233.30 +1.30
Merck & Co., Inc. (MRK.N) $55.20 +0.03
Sanofi SA (SASY.PA) €75.43 -0.54
Amgen, Inc. (AMGN.OQ) $170.00 -0.77
Gilead Sciences, Inc. (GILD.OQ) $72.44 +0.03
Incyte Corporation (INCY.OQ) $105.47 -1.01

Earnings vs. Estimates